[News playback] As shown by statistics of over 300 hospitals in 16 cities by  Chinese Pharmaceutical Association in 2004, eights products produced by YRPG such as "Levofloxacin HydrocHoride Injection", "Roxithromycin Capsules" and "Enalapril Maleate Tablets", etc. were topped in the market share of the same drugs in China.
[Interpretation] With the unceasing price decrease in recent years and the promulgation of a series of policies restricting the sales of antibiotics, several pharmaceutical enterprises have been facing unprecedented challenges to survive. In the highly homogenized and scorching competition, YRPG’s development in plight and being ranked on the top among national pharmaceutical enterprises for successive three years in terms of the sales volume greatly depend on its advantageous product cluster and new product "combination fist" which are cultivated by the group elaborately for many years and have thus seized the commanding point of the market.
[Demonstration] The continuous high-and-new scientific and technological products have created incomparable product cluster advantages of YRPG. They’ve stood out in the homogenized competition and initiated the new era of Chinese stomach drugs. The new drug at the national level, "Jingqianping Granules" for treating the female’s premenstrual syndrome, has completed the market blank and been listed as the key promotion engineering by Chinese Medical Association. Epalrestat, a new drug for treating diabetes as developed by the group for five years, has filled domestic blank of treating diabetes neuropathy and Micro-blood vessel pathology as the first aldose reductase inhibitor in China.
YRPG has given a full play to the variety diversification and the product’s high-and-new technology advantages to ignite one and another market lights. Such brand halos as "National TCM Protective Variety" and "Famous TCM Product" have also illuminated the internationalization course of the group. at present, the group has already have 20 varieties sold in Europe, Mid-East, Singapore, Indonesia, Guinea, China Hongkong and other countries and regions.